Masimo Corporation, a medical technology company, develops, manufactures, and markets various noninvasive monitoring technologies worldwide. The company provides its products directly and through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, veterinarians, long term care facilities, and consumers. The company’s core business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. The company’s product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. In addition, the company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor, and the Radius-7 wearable wireless patient monitor. The company has also developed the Patient SafetyNet remote patient surveillance monitoring system, which allows approximately 200 patients to be monitored simultaneously and remotely through a PC-based viewing station or by care providers through their pagers, voice-over-IP phones or smartphones. The company’s solutions and related products are based upon its proprietary Masimo SET and rainbow algorithms. These technologies are incorporated into various product platforms depending on its customers’ specifications. In addition, the company provides its technologies to original equipment manufacturers in a form factor that is easy to integrate into their patient monitors, defibrillators and infant incubators. The company’s technology is supported by an intellectual property portfolio that it has built through internal development, and to a lesser extent, acquisitions and license agreements. The company has also licensed from Cercacor Laboratories, Inc. the right to certain original equipment manufacturer rainbow technologies and to incorporate certain rainbow technology into the company’s products intended to be used by professional caregivers, including but not limited to, hospital caregivers and alternate care facility caregivers. Products and Markets The company develops, manufactures, and markets patient monitoring technologies that incorporate a monitor or circuit board and sensors, including proprietary single-patient-use, reusable and rainbow ReSposable sensors and patient cables. In addition, the company offers remote alarm/monitoring solutions, software and connectivity solutions. Circuit Boards Masimo SET MS Circuit Boards The company’s Masimo SET MS circuit boards perform all signal processing and other pulse oximetry functions incorporating the Masimo SET platform. The company’s MS circuit boards are included in its proprietary monitors for direct sale or sold to the company’s original equipment manufacturer partners for incorporation into their monitors. Once incorporated into a pulse oximeter, the MS circuit boards perform all data acquisition processing and report the pulse oximetry levels to the host monitor. The circuit boards and related software interface directly with the company’s proprietary sensors to calculate arterial blood oxygen saturation level and pulse rate. The company’s new generation boards include the MS-2003, MS-2011, MS-2013, and MS-2040, with a typical power consumption of approximately 45 milliwatts. Masimo rainbow SET MX Circuit Boards The company’s next-generation circuit board is the foundation for its Masimo rainbow Pulse CO-Oximetry and rainbow Acoustic Monitoring platform, utilizing certain technology that is licensed from Cercacor Laboratories, Inc. The MX circuit boards offer full functionality of the company’s rainbow technology for noninvasive measurements for total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet), and acoustic respiration rate (RRa), in addition to providing measure-through-motion and low-perfusion oxygen saturation (SpO2), pulse rate and PI measurement capabilities of Masimo SET pulse oximetry. The company’s MX-5 original
(MASI:Consolidated Issue Listed on NASDAQ Global Select )
Irvine, CA 92618
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.
|No competitor information is available for MASI.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact MASIMO CORP, please visit www.masimo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.